malondialdehyde has been researched along with amphotericin b in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freitag, T; Heidemann, H; Heydemann, J; Holzlöhner, U; Inselmann, G | 1 |
Barreto-Bergter, E; Haido, RM | 1 |
Brajtburg, J; Medoff, G; Vertut-Croquin, A | 1 |
Brajtburg, J; Elberg, S; Kobayashi, GS; Medoff, G; Schlessinger, D; Schwartz, DR; Vertut-Croquin, A | 1 |
Markov, AK; Olinde, KD; Rao, MR | 1 |
Aksu, O; Altuntaş, A; Bayram, DŞ; Demir, M; Gökçimen, A; Sezer, MT; Uz, E; Yılmaz, HR | 1 |
Ali, EM; Fahmy, SR; Soliman, AM | 1 |
7 other study(ies) available for malondialdehyde and amphotericin b
Article | Year |
---|---|
Effect of amphotericin B on hepatic cytochrome P-450 and glucose-6-phosphatase in the rat.
Topics: Amphotericin B; Analysis of Variance; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Glucose-6-Phosphatase; Kinetics; Liver; Male; Malondialdehyde; Microsomes, Liver; Organ Size; Rats; Rats, Inbred Strains; Reference Values | 1992 |
Amphotericin B-induced damage of Trypanosoma cruzi epimastigotes.
Topics: Amphotericin B; Animals; Fatty Acids; Malondialdehyde; Oxidation-Reduction; Sterols; Superoxides; Trypanosoma cruzi | 1989 |
Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Line; Dactinomycin; Drug Synergism; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Lomustine; Malondialdehyde; Oxidation-Reduction; Potassium; Thymidine | 1986 |
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
Topics: Amphotericin B; Ascorbic Acid; Carboxyhemoglobin; Catalase; Cell Membrane Permeability; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Light; Malondialdehyde; Oxidation-Reduction; Potassium; Time Factors | 1985 |
Protection from amphotericin B-induced lipid peroxidation in rats by fructose-1,6-diphosphate.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Fructosediphosphates; Heart; Heart Arrest; Immunologic Factors; Kidney; Lipid Peroxidation; Liver; Lung; Male; Malondialdehyde; Myocardium; Rats; Rats, Sprague-Dawley | 1997 |
Caffeic acid phenethyl ester protects against amphotericin B induced nephrotoxicity in rat model.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Caffeic Acids; Catalase; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Phenylethyl Alcohol; Rats; Superoxide Dismutase | 2014 |
Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Glutathione; Humans; Invasive Pulmonary Aspergillosis; Liver; Male; Malondialdehyde; Mice; Neutropenia; Oxidative Stress; Pigments, Biological; Sepia; Superoxide Dismutase | 2014 |